Company Search:
Advanced Search
Sponsored Links
Grifols SA Company Snapshot
Grifols SA operates in the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Grifols SA with three other pharmaceutical manufacturers in Europe: Protek PAO of Russia (2017 sales of 258.45 billion Russian Rubles [US$3.90 billion] of which 78% was Distribution), Lonza Group AG of Switzerland (5.11 billion Swiss Francs [US$5.08 billion] of which 47% was Specialty Ingredients), and UCB Sa which is based in Belgium (4.53 billion Euro [US$5.12 billion] of which 100% was Biopharmacy).

Sales Analysis. Grifols SA reported sales of 4.32 billion Euro (US$4.88 billion) for the year ending December of 2017. This represents an increase of 6.6% versus 2016, when the company's sales were 4.05 billion Euro. Sales at Grifols SA have increased during each of the previous five years (and since 2012, sales have increased a total of 65%). Sales of Bioscience saw an increase of 6.2% in 2017, from 3.23 billion Euro to 3.43 billion Euro. Not all segments of Grifols SA experienced an increase in sales in 2017: sales of Others/raw Materials fell 69.0% to 18.26 million Euro. (However, this segment's sales were only a very small portion of the company's overall sales).
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Grifols SA
  Stock Performance Chart for Grifols SA
  Stock Data: Recent Stock Performance:
  Current Price (2/15/2019): 23.80
(Figures in Euro)
1 Week 5.8%   13 Weeks -2.6%  
4 Weeks -8.5%   52 Weeks 0.8%  
Grifols SA Key Data:
  Ticker: GRF Country: Spain
  Exchanges: MAD Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2017 Sales 4,318,073,000
(Year Ending Jan 2018).
Employees: 18,309
  Currency: Euro Market Cap: 10,141,889,192
  Fiscal Yr Ends: December Shares Outstanding: 426,129,798
  Share Type: Accion Closely Held Shares: 145,690,603
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.